Guy Chatelain

Director/Board Member at

EUSA Pharma SAS

Health Technology

Commercial Services

Finance

Profile

Guy Chatelain is currently a Director at EUSA Pharma SAS, Indufina, Industrielle et Financière Holding Genève SA, Cellmark SA, Ms Medical Synergy SA, a Member of the Swiss Bar Association, Geneva Association of Business Law, and Geneva Bar Association.
He was previously the President & Managing Director at Seventure Partners SA, a Director at Orphan Synergy Europe-Pharma SA, and a Director at OSE Immunotherapeutics SA from 2012 to 2018.
He was also a Principal at Pestalozzi Lachenal Patry from 1977 to 1984 and a Partner & Attorney at Law at Mentha & Associés.
Mr. Chatelain holds an MBA from École des Hautes Études Commerciales de Paris.

Guy Chatelain active positions

Companies	Position	Start
Geneva Bar Association	Corporate Officer/Principal	-
Swiss Bar Association Swiss Bar Association Swiss Bar Association is a company. 'The company is based in Bern, Switzerland.	Corporate Officer/Principal	-
Geneva Association of Business Law	Corporate Officer/Principal	-
EUSA Pharma SAS EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases	Director/Board Member	-
Ms Medical Synergy SA Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Director/Board Member	-
Cellmark SA Cellmark SA Wholesale DistributorsDistribution Services Wholesales cellulose and paper products	Director/Board Member	-
Indufina, Industrielle et Financière Holding Genève SA	Director/Board Member	-

All active positions of Guy Chatelain

Former positions of Guy Chatelain

Companies	Position	End
OSE IMMUNOTHERAPEUTICS	Director/Board Member	03/01/2018
Seventure Partners SA Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million.	Chief Executive Officer	01/01/2013
░░░░░░░░░░ ░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Guy Chatelain's experience

Training of Guy Chatelain

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Guy Chatelain's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Pestalozzi Lachenal Patry Pestalozzi Lachenal Patry Miscellaneous Commercial ServicesCommercial Services Provides legal services	Commercial Services
Seventure Partners SA Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million.	Finance
École des Hautes Études Commerciales de Paris École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Mentha & Associés Mentha & Associés Miscellaneous Commercial ServicesCommercial Services Provides legal services	Commercial Services
EUSA Pharma SAS EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases	Health Technology
Swiss Bar Association Swiss Bar Association Swiss Bar Association is a company. 'The company is based in Bern, Switzerland.
Geneva Association of Business Law
Geneva Bar Association
Indufina, Industrielle et Financière Holding Genève SA
Cellmark SA Cellmark SA Wholesale DistributorsDistribution Services Wholesales cellulose and paper products	Distribution Services
Orphan Synergy Europe-Pharma SA Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Health Technology
Ms Medical Synergy SA Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
OSE Immunotherapeutics SA OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Health Technology